Results 231 to 240 of about 4,420,277 (273)

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Little red dots as young supermassive black holes in dense ionized cocoons. [PDF]

open access: yesNature
Rusakov V   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy